Literature DB >> 24823780

Pseudogenes: a novel source of trans-acting antisense RNAs.

Per Johnsson1, Kevin V Morris, Dan Grandér.   

Abstract

While long thought to represent only "junk" DNA, several recent studies support a functional role for pseudogenes. Several hundreds of pseudogenes have been reported as transcribed into RNA in a large variety of tissues and tumors. Most studies have focused on pseudogenes expressed in the sense direction, but some reports suggest that pseudogenes can be also transcribed as antisense RNAs (asRNAs). A few examples of key regulatory genes, such as PTEN and OCT4, have in fact been reported to be under the regulation of pseudogene-expressed asRNAs. Here, we review what is known about pseudogene-expressed asRNAs and we discuss the functional role that these transcripts may have in gene regulation. Finally, we discuss some technical challenges when characterising the function of pseudogene asRNAs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24823780     DOI: 10.1007/978-1-4939-0835-6_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Natural variability of minimotifs in 1092 people indicates that minimotifs are targets of evolution.

Authors:  Kenneth F Lyon; Christy L Strong; Steve G Schooler; Richard J Young; Nervik Roy; Brittany Ozar; Mark Bachmeier; Sanguthevar Rajasekaran; Martin R Schiller
Journal:  Nucleic Acids Res       Date:  2015-06-11       Impact factor: 16.971

2.  Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA.

Authors:  Michele Scarola; Elisa Comisso; Rhena Pascolo; Riccardo Chiaradia; Rosa Maria Marion; Claudio Schneider; Maria A Blasco; Stefan Schoeftner; Roberta Benetti
Journal:  Nat Commun       Date:  2015-07-09       Impact factor: 14.919

3.  Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi.

Authors:  Pablo Smircich; Guillermo Eastman; Saloe Bispo; María Ana Duhagon; Eloise P Guerra-Slompo; Beatriz Garat; Samuel Goldenberg; David J Munroe; Bruno Dallagiovanna; Fabiola Holetz; Jose R Sotelo-Silveira
Journal:  BMC Genomics       Date:  2015-06-09       Impact factor: 3.969

4.  A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome.

Authors:  Walter Arancio; Swonild Ilenia Genovese; Lucia Bongiovanni; Claudio Tripodo
Journal:  Oncoscience       Date:  2015-11-11

5.  Nuclear Compartmentalization Contributes to Stage-Specific Gene Expression Control in Trypanosoma cruzi.

Authors:  Lucía Pastro; Pablo Smircich; Andrés Di Paolo; Lorena Becco; María A Duhagon; José Sotelo-Silveira; Beatriz Garat
Journal:  Front Cell Dev Biol       Date:  2017-02-13

6.  The pseudogene-derived long non-coding RNA SFTA1P suppresses cell proliferation, migration, and invasion in gastric cancer.

Authors:  Hongwei Ma; Tianshi Ma; Miao Chen; Zigui Zou; Zhihong Zhang
Journal:  Biosci Rep       Date:  2018-04-20       Impact factor: 3.840

7.  Complex Analysis of Retroposed Genes' Contribution to Human Genome, Proteome and Transcriptome.

Authors:  Magdalena Regina Kubiak; Michał Wojciech Szcześniak; Izabela Makałowska
Journal:  Genes (Basel)       Date:  2020-05-12       Impact factor: 4.096

8.  Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.

Authors:  Ruichao Chen; Minfen Zhang; Wenya Liu; Hui Chen; Tonghui Cai; Hanzhen Xiong; Xiujie Sheng; Shaoyan Liu; Juan Peng; Fang Wang; Hao Chen; Wanrun Lin; Xuehu Xu; Wenxin Zheng; Qingping Jiang
Journal:  Cell Death Dis       Date:  2018-12-18       Impact factor: 8.469

9.  Pseudogene ACTBP2 increases blood-brain barrier permeability by promoting KHDRBS2 transcription through recruitment of KMT2D/WDR5 in Aβ1-42 microenvironment.

Authors:  Qianshuo Liu; Xiaobai Liu; Defeng Zhao; Xuelei Ruan; Rui Su; Xiuli Shang; Di Wang; Chunqing Yang; Yixue Xue
Journal:  Cell Death Discov       Date:  2021-06-14

Review 10.  Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.

Authors:  Sarah Blagden; Mai Abdel Mouti; James Chettle
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-08-01       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.